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The zinc-ﬁnger transcription factors of the kruppel-like factor family (KLF) are critical in many
physiological and pathological processes including cell proliferation, differentiation, inﬂammation,
and apoptosis. Recently, there is increasing evidence that suggests these KLFs have an important role in
fat biology. This review summarizes the role of KLFs in lipid metabolism, especially in adipogenesis, and
reveals the relationship networks among members of KLF family in differentiation.
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The worldwide prevalence of overweight and obesity is rapidly
increasing, and this negatively impacts the health of humans
(Flier, 2004). Obese individuals are more likely than their lean
counterparts to develop cardiovascular disease, type 2 diabetesll rights reserved.mellitus, metabolic disorders, and some cancers (Flier, 2004).
Excessive fat accumulation reﬂects an imbalance between energy
expenditure and caloric intake, which leads to an increase in the
number and/or size of fat cells. Adipocytes can be enlarged by
excessive lipid deposition or generated from precursor ones. The
essential step of adipocyte differentiation is the commitment
from preadipocytes to adipocytes.
Differentiation of preadipocyte into adipocyte is regulated by an
elaborate network of transcription factors that coordinate expres-
sion of hundreds of genes responsible for fat-cell phenotype (Rosen
and MacDougald, 2006; Rosen and Spiegelman, 2000). Peroxisome
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master regulator of adipogenesis among transcription factors in
particular (Barak et al., 1999; Rosen et al., 1999; Tontonoz et al.,
1994). Without it, precursor cells are incapable of expressing any
known aspect of the adipocyte phenotype (Zhang et al., 2004). The
CCAAT/enhancer-binding protein (C/EBP) family plays a vital role in
promoting adipocyte differentiation. C/EBPb and C/EBPd are induced
early during the differentiation of 3T3-L1 preadipocytes upon
hormonal stimulation (Tanaka et al., 1997; Wu et al., 1996, 1995),
which is followed by the induction of PPARg and C/ERPa. C/EBPa,
whose expression is highest during later stages of differentiation,
is induced by PPARg activation. Krox20 (Chen et al., 2005), sterol-
regulatory element-binding protein (SREBP)-1c (Kim et al., 1998a,
1998b; Kim and Spiegelman, 1996), and Stat5 (Kawai et al., 2007;
Meirhaeghe et al., 2003; Nanbu-Wakao et al., 2002) have also been
shown to be important in adipogenesis.
Members of the Kruppel-like factor (KLF) family of zinc-ﬁnger
transcription factors have recently been identiﬁed as key regula-
tors of cell activity and have received intensive investigations in
human health and disease (McConnell and Yang, 2010). KLF is
derived from the Drosophila protein ‘‘kruppel’’ (meaning ‘‘crip-
ple’’) which shares homology of proteins to the DNA-binding
domains. Drosophila embryos deﬁcient in kruppel die with con-
sequences of abnormal thoracic and abdominal segmentation and
thus appeared ‘‘crippled’’ (Nusslein-Volhard and Wieschaus, 2003;
Zuo et al., 1991). The distinguishing feature of the KLF family is the
presence of three highly conserved classical Cys2/His2 zinc ﬁngers
(Bieker, 2001; Dang et al., 2000b; Turner and Crossley, 1999), a
motif that is the most abundant in transcription factors and the
second most abundant in the human genome (Bieker, 2001). Zinc
ﬁngers 1 and 2 contain 23 residues, while the third ﬁnger has only
21 residues (Pearson et al., 2008). These ﬁngers are located at the
carboxyl terminus of the protein and enable KLFs to bind to
related GC- and CACCC-boxes of DNA (Bieker, 2001; Dang et al.,
2000b; Pearson et al., 2008; Turner and Crossley, 1999). In
contrast to the zinc-ﬁnger regions, the non-DNA-binding regions
are highly divergent, modulate transactivation and transrepres-
sion, and often mediate interaction with various co-regulators,
giving KLFs unique tissue-speciﬁc roles (Pearson et al., 2009).Table 1
Current ﬁndings in Kruppel-like factors associated with fat biology.
Other name mRNA appea
Promoters
KLF4 Gut-enriched Kruppel-like factor 30 min post
GKLF/ZIF
KLF5 Intestinal-enriched Kruppel-like factor 1 h after stim
Basic transcription element-binding protein2
BTEB2, IKLF
KLF6 Core promoter binding protein Within 30 m
Zf9, CPBP/GBF
KLF15 Kidney-enriched Kruppel-like Factor 4 days after
KKLF
KLF9 Basic transcription element-binding protein1 4 days after
BTEB1
Suppressors
KLF3 Basic Kruppel-like factor Most highly
BKLF Diminished
KLF2 Lung Kruppel-like factor Most highly
LKLF Diminished
KLF7 Ubiquitous Kruppel-like factor Most highly
UKLFThe ﬁrst mammalian kruppel homolog, termed erythroid
Kruppel-like factor (EKLF/KLF1), was identiﬁed in 1993 as a factor
speciﬁcally expressed in the red blood cell lineage (Bieker, 1996;
Miller and Bieker, 1993; Parkins et al., 1995). With the ﬁrst KLF
isolation and identiﬁcation, a new subfamily of Kruppel-like
proteins, which has a total of 17 mammalian KLFs, has emerged.
These factors have been shown to have important roles in a
diverse array of cellular processes including hematopoiesis (Nuez
et al., 1995; Parkins et al., 1995), organ development (Wani et al.,
1999b), cardiac remodeling (Fisch et al., 2007; Shindo et al.,
2002), angiogenesis (Bhattacharya et al., 2005), monocyte activa-
tion (Das et al., 2006; Feinberg et al., 2005), neoplasia (Rowland
et al., 2005; Wei et al., 2005), gluconeogenesis (Gray et al., 2007),
cell growth regulation (Black et al., 2001), and endothelial cell
function (Lin et al., 2005; Sen-Banerjee et al., 2005). In recent
years, many members of KLF have been identiﬁed to be involved
in both adipogenesis and lipogenesis. This review focuses on the
role of the KLF family members as promoters or inhibitors in fat
biology and also their role in brown adipocyte tissue (summar-
ized in Table 1).KLFs that promote adipogenesis
KLF15
Kruppel-like factor 15 (KLF15) is the ﬁrst KLF found to be
involved in adipogenesis (Uchida et al., 2000), which is initially
identiﬁed as a protein that binds to CLC-K1 promoter, a kidney-
speciﬁc CLC chloride channel, thus formerly designated kidney
KLF (KKLF). Northern blot analysis shows KLF15 expression to be
more abundant in adipose, muscle (heart, skeletal muscle, and
aorta), kidney, and liver in mouse tissues (Uchida et al., 2000).
KLF15 is increased maximally at Day 6 in 3T3-L1 preadipo-
cytes differentiation (Mori et al., 2005). The time course of KLF15
mRNA up-regulation during adipocyte differentiation is in the late
phase of adipogenesis, about 4 days after the adipogenic stimu-
lation, 2 days later than the initial expression of PPARg and
aP2 mRNAs, which is similar to the pattern of C/EBPa mRNA.r time in adipogenesis Function/observation
induction  Interact with Krox20
 Transactivate C/EBPb
 Binding to the C/EBPbpromoter
ulation  Interact with C/EBPb/d
 Bind to the PPARg2 promoter
in  Associated with HDAC3
 Bind to the pre-1 promoter
induction  Regulate GLUT4
 Involved in gluconeogenesis
 Involved in amino acid catabolism
 Downstream of C/EBPb or C/EBPd
 Maintain differentiated state by mediating
PPARg in cooperation with C/EBPa
induction  Activate the PPARg2 promoter
 Act in concert with C/EBPa
at day 0  Recruite the corepressor protein CtBP
upon differentiation  Associate with the C/ebpa promoter
at day 0  Inhibite PPARg promoter
upon differentiation  Inhibite ADD1/SREBP1c expression
 Inhibite C/EBPa expression
at day 0  Effect the adipocytokine genes
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(MSCs) and mouse embryonic ﬁbroblasts (MEFs) is ﬁrst detected
at 12 h, peaking at 2 days after adipogenic induction, earlier than
that of C/EBPd expression (Asada et al., 2010). Inhibition of KLF15
function in 3T3-L1 cells, either by its dominant negative mutant
or by RNA interference, reduces the expression of PPARg, C/EBPa,
aP2, or GLUT4. Conversely, overexpression of wild-type KLF15
slightly increases PPARg levels on Day 1 and Day 2 after initiation
of differentiation. Ectopic expressed KLF15 in nonadipocyte cell
lines, such as NIH3T3 and C2C12, also exhibits marked lipid
accumulation and increase PPARg and aP2 expressions (Mori
et al., 2005).
It is well known that most transcription factors affect adipo-
genesis by recruiting PPARg. It is interesting to seek out whether
the effects of KLF15 in promoting adipocyte differentiation are
also dependent on the induction of PPARg. Mori T and his
coworkers found that overexpression of PPARg2 promoted non-
adipocyte cell line–NIH3T3 cells adipogenesis without changing
its KLF15 expression. The similar phenomenon was also observed
in MEFs derived from PPARg-/- mice infected with retroviral
vectors for PPARg2 (Mori et al., 2005). These ﬁndings reveal that
PPARg is a downstream effector in adipocyte differentiation
induced by KLF15 and KLF15 regulates adipogenesis via PPARg
expression. However, the potential binding sites of KLF15 to
PPARg promoter have not yet been identiﬁed. Similar methods
were applied to demonstrate that KLF15 also is a downstream
effector of C/EBPb or C/EBPd in PPARg induction during adipocyte
differentiation (Mori et al., 2005).
In addition to PPARg, a canonical adipogenic inducer during
adipogenesis, glucocorticoid receptor (GR) also plays critical role
in KLF15 gene expression in adipogenesis. GR stimulation is a
required step for in vitro adipogenesis (Ito et al., 2007). GR
inhibitor blocks human MSCs and MEFs adipogenesis and MEFs
from either GR-deﬁcient or GR-dimeried mice exhibited impaired
differentiation upon adipogenic induction. KLF15 expression was
increased during adipose differentiation and this induction was
suppressed either by RU486, a GR inhibitor or GR dysfunction
(Asada et al., 2010).
KLF15 overexpression in adipocyte promotes adipocyte
maturation and potentiates glucose transporter 4 (GLUT4) expres-
sion (Gray et al., 2002), and its role in regulating glucose
production via modulating enzymes involved in either gluconeo-
genesis or amino acid catabolism (Gray et al., 2007). Acetyl-CoA is
an important intermediate in energy production through the fatty
acid/cholesterol metabolic pathway and the citric acid cycle.
Acetyl-coA Synthetase (AceCS) is an enzyme that catalyzes the
production of acetyl-CoA from acetate and CoA. AceCS2 expres-
sion induced by fasting is contributed by KLF15 (Yamamoto et al.,
2004). Adrenomedullin, as a potent vasodilatory hormone pro-
duced by mature adipocytes, is increased in 3T3L1 adipocyte due
to KLF15 knockdown by RNA interference (Nagare et al., 2009).
Adipocyte-derived adrenomedullin plays a protective role in the
development of hypertension, insulin resistance, and the compli-
cations of these conditions in obese patients (Paulmyer-Lacroix
et al., 2006).
Mice with diet-induced obesity (DIO) or genetic obesity (ob/ob)
exhibit lower levels of KLF15 expression in adipose tissue com-
pared with normal controls (Nagai et al., 2009). KLF15 deﬁciency
mice are protected against high fat diet (HFD) induced insulin
resistance (IR) (Sartoretto et al., 2008) and also exhibit severe
hypoglycemia after an overnight fast (Gray et al., 2007). Recently,
evidence from Haldar et al. (2012) suggests that there are energy
and substrate ﬂux abnormalities in KLF15-/- mice during exercise.
These data put KLF15 as a central component in all three basic
cellular nutrients: Glucose, Amino acids, and Lipids metabolism.
It is thus reasonable to speculate that obesity-induced KLF15down regulation in adipose tissue is related to the pathogenesis
of obesity induced health disorders.
KLF5
KLF5, also known as BTEB2 or IKLF, was identiﬁed as a
transcription factor for SMemb/non-muscle myosin heavy
chain-B (NMHC-B) (Watanabe et al., 1999), a molecular marker
of smooth-muscle cells (Kuro-o et al., 1989; Manabe et al., 1997).
Normally, KLF5 expresses abundantly in developing blood vessels,
but downregulates in adult vessels (Watanabe et al., 1999).
However, its expression is strongly upregulated in activated
smooth-muscle cells or ﬁbroblasts (myoﬁbroblasts) in vascular
lesions (Hoshino et al., 2000). Mice with complete absence of
KLF5 show embryonic lethality by day E8.5 (Shindo et al., 2002)
due to defects in preimplantation embryo development (Ema
et al., 2008). Heterozygous KLF5 knockout mice are viable into
adulthood, but exhibit a marked deﬁciency in white adipose
tissue (WAT) development starting from day 3 after birth. Body
weight and WAT mass are markedly reduced in KLF5(þ/) mice
than in wild-type mice and greater numbers of smaller adipocytes
are observed in KLF5(þ/) WAT, which contain little or no lipid
(Oishi et al., 2005). When fed a HFD, KLF5(þ/) mice are better
protected from HFD-induced weight gain than their wild-type
littermates (Oishi et al., 2008). These ﬁndings suggest that KLF5
plays a key role in adipogenesis.
In in-vitro adipogenesis, KLF5 is induced in the early stages of
differentiation. The way to activate KLF5 is not well clariﬁed, but
at least overexpression of either C/EBPb or C/EBPd results in
induction of KLF5 promoter activity, which leads to KLF5 activa-
tion. Transfected 3T3L1 preadipocyte with KLF5 dominant-
negative mutant signiﬁcantly reduces lipid accumulation and
markedly suppresses PPARg and C/EBPa expressions. Similar
effects are also observed during 3T3-L1 differentiation when
knocked down by KLF5-siRNA (Oishi et al., 2005). MEFs derived
from KLF5(þ/) mice exhibit severely impaired adipocyte differ-
entiation and lower levels of PPARg and C/EBPa (Oishi et al.,
2005). Conversely, KLF5 overexpression spontaneously promotes
adipocyte differentiation, accompanied by PPARg and C/EBPa
upregulation, even without hormonal stimulation (Oishi et al.,
2005). Further studies demonstrate that KLF5 can directly bind to
the endogenous PPARg promoter, stimulating modest PPARg
promoter activity, and this effect can be enhanced in concert
with C/EBPb and C/EBPd. These data indicate that KLF5 is down-
stream of C/EBPb and C/EBPd, but upstream of PPARg during
adipocyte differentiation (Oishi et al., 2005).
KLF4
KLF4, ﬁrst isolated by encoding the zinc ﬁnger region of the
immediate-early transcription factor zif/268, is a gut-enriched
Kruppel-like factor (GKLF/ZIF) (Garrett-Sinha et al., 1996; Shields
et al., 1996). KLF4 is primarily expressed in postmitotic or
differentiated cells of the skin and the gastrointestinal tract and
possesses a variety of roles as differentiation–proliferation
switchers and cell cycle regulators (Garrett-Sinha et al., 1996;
Shields et al., 1996; Takahashi and Yamanaka, 2006; Yoon et al.,
2003). KLF4 expression can also be found in naive, quiescent B
lymphocytes and is rapidly down-regulated upon mitogenic
activation (Glynne et al., 2000). KLF4 knockout mice die 12 h
after birth due to defects in skin development, with a failure of
normal basement membrane formation (Segre et al., 1999).
In vitro, the expression of KLF4 is mainly in a growth-arrested
state caused by serum deprivation, contact inhibition, DNA
damage, or growth-inhibitory cytokines (Chen et al., 2000;
Zhang et al., 2000). The reduced expression is observed in
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(Dang et al., 2000a; Shie et al., 2000). During 3T3-L1 differentia-
tion, KLF4 expression is an early-stage event, and the expression
pattern is similar to that of the well-known transcription factors
C/EBPb. By knocking down KLF4, 3T3-L1 cells produce signiﬁ-
cantly less lipid than the controls, as well as adipogenic regulators
such as adipsin, aP2, and PPARg (Birsoy et al., 2008), making KLF4
a regulator in modulating adipocyte formation.
KLF4 regulates adipogenesis through transactivated C/EBPb by
directly binding to its promoter at the critical region between
1.438 kb and 1.134 kb, although a clear consensus sequence
remains to be identiﬁed. Krox20, known as a transcription factor,
also transactivates C/EBPb promoter via sequences between
1.45 kb and 1.1 kb (Chen et al., 2005). Krox20 and KLF4 can
bind to one another and activate C/EBPb as coactivators, thereby
overexpression of both Krox20 and C/EBPb can partially overcome
KLF4 knockdown (Birsoy et al., 2008). As the expression patterns
of C/EBPb, Krox20, and KLF4 are similar, further exploration ﬁnds
that C/EBPb deﬁcient cells show increasing Krox20 and KLF4
levels, while C/EBPb overexpression exhibits a strongly decrease
in KLF4, and to a lesser extent in Krox20 expression, indicating a
potential negative feedback mechanism (Birsoy et al., 2008).
Notably, once aP2 promoter turns on, KLF4 expression may not
be required at later stage of adipogenesis.
KLF6
KLF6 is originally identiﬁed as a quickly induced gene follow-
ing hepatic stellate cells activation (Koritschoner et al., 1997;
Lalazar et al., 1997; Ratziu et al., 1998; Suzuki et al., 1998). It is
also a novel tumor suppressor gene frequently mutated in human
prostate and colon cancers (Narla et al., 2001; Reeves et al., 2004),
which is mainly through transcriptional up-regulation of
p21waf1/cdi. Transcriptional targets of KLF6 include transforming
growth factor-b1(TGFb1) and its receptors (TGFb1R) (Kim et al.,
1998c), urokinase-type plasminogen activator(uPA) (Kojima et al.,
2000), and the human immunodeﬁciency virus-long terminal
repeat (HIV-LTR) (Suzuki et al., 1998).
As to adipogenesis, KLF6 promotes preadipocyte differentia-
tion by repressing a factor named Delta-like1 (Dlk1). Dlk1, a key
regulator of adipogenesis, also known as preadipocyte factor-1
(pref-1), has a function to prevent 3T3-L1 preadipocytes differ-
entiation through its sustained expression (Smas and Sul, 1993).
The dramatic down-regulation of Dlk1 after hormonal stimulation
in preadipocytes is an early and necessary event in the fat cells
phenotypic conversion. Dlk1 expressions in both NIH3T3 cells and
3T3-L1 preadipocytes are remarkably suppressed by stably trans-
fected with KLF6. KLF6’s induction occurs on day 0 after hormonal
stimulation (Inuzuka et al., 1999; Li et al., 2005) via transcrip-
tionally repressing Dlk1 expression and thereby promotes 3T3-L1
differentiation. The precise mechanism of KLF6 is that it can
directly bind to the GC element in Dlk1 promoter (Li et al., 2005),
which is enhanced by interacting with HDAC3, a member of the
class I Rpd 3-like histone deacetylases (Fajas et al., 2002). HDAC3
acts as a corepressor of KLF6, and HDAC3 can interact directly
with KLF6 without any other accessory factor to form a stable
complex to repress Dlk1 expression (Li et al., 2005). However, the
direct role for KLF6 in adipocyte differentiation has not been
reported to date, and future efforts should be made to explore its
function in adipogenesis.
KLF9
KLF9 is a new member of KLF family involved in adipogenesis,
which is previously designated as basic transcription element-
binding protein-1 (BTEB1) (Imataka et al., 1992). The functions ofKLF9 in many biological processes have been found. KLF9 reg-
ulates the transactivation of progesterone-responsive promoters
and has been found to be downregulated in endometrial carci-
noma and colorectal cancer (Kang et al., 2008; Simmen et al.,
2008, 2010). Mice lacking KLF9 show impairments in motor
learning, motor coordination and fear-conditioning (Morita
et al., 2003). Increased expression of KLF9 in a human endome-
trial carcinoma cells leads to serum-dependent proliferation
(Zhang et al., 2001). KLF9 is also shown to regulate crypt-villus
cell renewal in mice (Simmen et al., 2007) and secondary anti-
body responses of human splenic B cells (Good and Tangye, 2007).
Induction of KLF9 during adipogenesis appears at the middle
stage of differentiation and gradually increases throughout the
middle and late stages. KLF9 expression pattern in 3T3-L1 cells is
similar to that of previously reported late transcription factors for
adipogenesis such as PPARg and C/EBPa, but different from that of
early transcription factors such as C/EBPb or C/EBPd (Pei et al.,
2010). Notably, KLF9 can be directly activated by glucocorticoid
stimulation during adipogenesis (Asada et al., 2010), although
further study is needed to verify it. The role of KLF9 to promote
adipocyte differentiation has been well discussed. Knockdown
KLF9 with siRNA suppresses a variety of adipogenic genes expres-
sion, including PPARg, C/EBPa and aP2, as well as adipocyte
differentiation, whereas overexpression of KLF9 does not upregu-
late C/EBPa or PPARg levels (Pei et al., 2010). KLF9 is required in
adipogenesis, but its expression is not sufﬁcient to perform a full
process of adipocyte differentiation, and it needs to interact with
accessorial factors. KLF9 promotes differentiation by binding to the
PPARg2 promoter in 413 to 247 region directly and transacti-
vating PPARg2 activity, and this effect is more signiﬁcant in concert
with C/EBPa through their physical interaction (Pei et al., 2010).KLFs that inhibit adipogenesis
KLF2
KLF2 is highly expressed in the lung with limited distribution
in other organs, initially identiﬁed through a homology screening
strategy using the zinc ﬁnger domain of KLF1 (Anderson et al.,
1995; Wani et al., 1999a). KLF2 plays a vital role in the develop-
ment of the lung (Wani et al., 1999b). Targeted deletion of KLF2
resulted in mice death around 12.5 days of gestation due to
abnormal blood vessel development which forms severe hemor-
rhage, indicating an essential role in embryonic development
(Kuo et al., 1997; Wani et al., 1998).
KLF2 is highly expressed in both human and 3T3-L1 preadi-
pocytes, and dramatically diminish upon adipocyte differentiation
as signiﬁcantly downregulate KLF2 promoter activity (Banerjee
et al., 2003; Lee et al., 2010a; Wu et al., 2005). Overexpression of
KLF2 in 3T3-L1 cells shows a decrease in intracellular lipid
accumulation as well as in transcription factors induction of
PPARg, ADD1/SREBP1c and C/EBPa but not C/EBPb or C/EBPd
(Banerjee et al., 2003). The consequence of excess KLF2 expression
blocks preadipocyte differentiation into adipocyte. By using tet-
response 3T3-L1 cell lines, Wu J and his coworker found that
physiological level re-expression of KLF2 prevents preadipocyte
differentiation partially through DLK1 restoration (Wu et al.,
2005), which seems like an opposite effect to KLF6 but needs
more further study. KLF2 does not affect the commitment of
pluripotent stem cells into the preadipocytic lineage. MEFs
derived from KLF2 null mouse embryos retain the ability to
differentiate efﬁciently into adipocytes upon adipogenic stimula-
tion and are even more prone to initiate differentiation at the
early stage (Wu et al., 2005), illustrating that KLF2 exhibits as a
natural repressor in preadipocyte differentiation.
Z. Wu, S. Wang / Developmental Biology 373 (2013) 235–243 239To date, a series of experiments has been conducted to explore
the mechanism of KLF2 pathway. KLF2 exerts its repression
during adipogenesis through binding to PPARg2 promoter directly
and inhibits the promoter activity (Banerjee et al., 2003). How-
ever, the mutation of the kruppel binding site of PPARg2 promo-
ter alone is not sufﬁcient to completely abrogate KLF2-mediated
inhibition of promoter activity, suggesting that non-DNA binding-
dependent mechanisms are probably involved for the full inhibi-
tory effect (Banerjee et al., 2003). Furthermore, study from human
adipose tissue derived mesenchymal stem cells shows that ultra-
violet A inhibits adipogenic differentiation by KLF2 induction,
which is mediated by migration inhibitory factor (MIF)-AMPK
signaling (Lee et al., 2010b).
KLF3
KLF3 is most highly expressed in erythroid cells, and other
tissues most notably in the midbrain region of embryonic mice,
also known as basic kruppel-like factor (BKLF) (Crossley et al.,
1996). KLF3 plays a role in hematopoiesis, as KLF3 deﬁcient mice
suffer from a myeloproliferative disorder (Funnell et al., 2007;
Turner and Crossley, 1999). Previous study also demonstrated
that KLF3 expression is associated with B cell transformation
(Pearson et al., 2011).
Size and body weight of KLF3 null mice are signiﬁcantly
smaller than both their wild-type and heterozygous counterparts
by the time of weaning (Sue et al., 2008). Histological sections and
the total DNA content of epididymal fat pads suggest smaller and
fewer cells in fat pats in homozygous KLF3 deletion mice (Sue
et al., 2008).
However, in vitro cell culture shows an opposite results. KLF3
is abundant in 3T3-L1 preadipocyte and decreases markedly upon
adipogenic stimulation. The time course of KLF3 expression is the
same to that of KLF2, suggesting that their function may be
similar. Overexpression of KLF3 by a retroviral system shows an
inhibition in 3T3-L1 preadipocyte differentiation (Sue et al.,
2008). MEFs form KLF3 null mice display enhanced ability to
accumulate lipid compared to wild-type ones (Sue et al., 2008).
It is well known that KLF3 suppresses transcription by recruit-
ing the corepressor protein CtBP (Turner and Crossley, 1998), a
cellular protein which binds to a Pro-X-Asp-Leu-Ser (PXDLS)
motif. Forced overexpression of KLF3 suppresses 3T3L1 preadipo-
cyte differentiation, while mutant PXDLS prevents CtBP binding to
KLF3 exhibits no blocking effect on adipogenesis, suggesting that
CtBP recruitment is required for KLF3 in regulating adipocyte
differentiation (Sue et al., 2008). MEFs from either CtBP deﬁcient
or KLF3 deﬁcient mice exhibit eleveated expression of C/EBPa.
Higher level of C/EBPa is also found in KLF3 Knocking down cells.
Experimentation with 3T3L1 preadipocytes shows that KLF3 can
directly bind to the endogenous C/EBPa promoter and repress its
activity.
KLF7
KLF7 is originally identiﬁed by a degenerative PCR approach
using a cDNA library from human vascular endothelial cells
(Matsumoto et al., 1998). Due to its expression in wide variety
of human tissues, KLF7 was named the ubiquitous kruppel-like
factor (UKLF), although it is known to be predominantly
expressed in the brain and the spinal cord in humans, and in
the central and peripheral nervous system during embryogenesis
in mice (Matsumoto et al., 1998). KLF7 is also identiﬁed as a
transcriptional activator and is shown to be capable of increasing
p21 WAF1/Cip1 expression (Laub et al., 2001).
The KLF7 protein is abundant in 3T3-L1 preadipocytes. It
dramatically decreases at 24hrs upon adipogenic stimulation,and gradually increases afterwards until it restores its level of
preadipocytes at day 7 of differentiation (Cho et al., 2007;
Kanazawa et al., 2005; Kawamura et al., 2006). Differentiation
of the human preadipocytes is remarkably inhibited by KLF7
overexpression (Cho et al., 2007; Kanazawa et al., 2005;
Kawamura et al., 2006). PPARg, C/EBPa, aP2, and adipsin decrease
signiﬁcantly in KLF7 overexpressing cells, whereas C/EBPb and
C/EBPd are not affected (Kawamura et al., 2006). In addition to
altering adipogenic modulations, KLF7 also exerts regulatory roles
in insulin sensitivity. Overexpressing KLF7 in human adipocyte
decreases leptin and adiponectin levels and increases IL6 produc-
tion, while overexpressing KLF7 in HIT-T15 (insulin secreting cell
line) cells suppresses insulin secretion and glucose transport
2(GLUT2), pancreatic duodenal homeobox factor 1 expressions
(Kawamura et al., 2006). However, the precise role of KLF7 in the
pathogenesis of type 2 diabetes through insulin regulation
requires further study.KLFs in brown adipocytes
Brown adipocytes (Cannon and Nedergaard, 2004), which are
multilocular lipid storage cells containing a large amount of
mitochondria, are grouped in brown adipose tissue (BAT) depots.
BAT are particularly found in the interscapular, subscapular,
axillary and intercostal regions of small mammals as well as
human and other large mammalian newborns. The main function
of brown adipocytes is in non-shivering thermogenesis in large
mammals after birth. Brown adipocytes are innervated by sym-
pathetic nervous system (SNS) nerve endings, which release
noradrenaline (NA) to stimulate brown adipocytes and uncou-
pling protein 1(UCP1) (Gesta et al., 2007; Nedergaard et al., 2005).
UCP1 is a unique factor of brown adipocytes to generate heat,
located in the mitochondrion and UCP1, induced or repressed by
factors such as cold, diet, leptin, corticosterone and obesity (Sell
et al., 2004). Several growth factors and transcription factors,
including BMP-7 (Tseng et al., 2008), PRDM16 (Seale et al., 2007),
and PGC-1a (Puigserver et al., 1998) have been suggested to have
central roles in brown adipocyte differentiation and UCP1 regula-
tion. CRE (cAMP response element), TRE/RARE (thyroid hormone
response element/retinoic acid response element), and PPRE
(PPAR response element) also have been reported to control
UCP1 gene expression.
Kruppel-like factors containing KLF11 and KLF15 have recently
been identiﬁed to be involved in UCP1 regulation (Klingenspor,
2003), with especially KLF11 mainly expressed in pancreatic b
cells and associated with type 2 diabetes (Neve et al., 2005).
Expression of KLF11 and KLF15 is rapidly induced and remains at
high levels through brown adipocyte differentiation of muBM3.1
cells (Yamamoto et al., 2010). Forced expression of KLF11, but not
KLF15, in muBM3.1 cells induces UCP1 expression at an appreci-
able level during brown adipogenic differentiation (Yamamoto
et al., 2010). Conversely, siRNA knockdown KLF11 completely
abolishes UCP1 protein expression in differentiating muBM3.1
cells, whereas muBM3.1 cells transfected with siRNAs for KLF15
has partial inhibitory effect on UPC1 (Yamamoto et al., 2010).
Study also demonstrated that KLF11 and KLF15 activate the
UCP1 promoter via directly binding to its region Sp1RE-2 and
Sp1RE-4, respectively (Yamamoto et al., 2010). Cooperative action
of KLF11 and KLF15 on the UCP1 promoter is essential for UCP1
induction in the process of brown adipogenic differentiation.
However, KLF11 and/or KLF15 can not initiate brown adipocyte
differentiation, suggesting that activation of KLF11 and/or KLF15
is necessary but not sufﬁcient to induce brown adipocyte
adipogenesis.
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adipogenesis
Currently, a total of 8 members in KLF family have been found
to be involved in adipogenesis, and they express sequentially in
the process of adipocyte differentiation (showed in Fig. 1). KLF2,
KLF3 and KLF7 are ﬁrst expressed in 3T3-L1 preadipocytes at high
level, and the amounts of these three proteins decrease rapidly
after hormonal cocktail stimulation. The three of KLFs play a role
in the negative regulation of adipogenesis, although the mechan-
isms are different and their down-regulation following differen-
tiation is an early and necessary event in the phenotypic
conversion to fat cells. KLF2 in preadipocytes exerts its inhibition
on PPARg expression through directly binding to the promoter of
PPARg within the 0.6-kb upstream region (Banerjee et al., 2003;
Wu et al., 2005), whereas KLF3 is directly associated with C/EBPa
promoter by recruiting its corepressor protein CtBP (Sue et al.,
2008). KLF7 down-regulate the expression of both PPARg and
C/EBPa, although little is known about the mechanism.
In the early phase of adipocyte differentiation, KLF4, KLF5 and
KLF6 are detected at about 30 min to 1 h after initiation. KLF6 is
the only repressor that promotes adipogenesis by inhibiting DLK1
expression (Li et al., 2005). KLF4 appears to contribute to
adipocyte differentiation by stimulating the expression of C/EBPb
and C/EBPd together with the previously described transcription
factor Krox20 (Birsoy et al., 2008). KLF5 induces PPARg expression
in coordination with C/EBPb and C/EBPd at an early phase of
differentiation (Oishi et al., 2005).
KLF9 mRNA signiﬁcantly increases from day 4 of the differ-
entiation and reaches the maximum at day 7 during the middle
and late phases of adipogenesis. KLF9 activates PPARg via directly
binding to 304 bp and 119 bp regions of the PPARg2 promo-
ter, and the transactivation effects is enhanced in concert with
C/EBPa (Pei et al., 2010). KLF15 also appears in 3T3-L1 cells 4 days
after the hormone induction, and its abundance is increased
maximally from Day 6 to Day 8. KLF15 is induced by C/EBPb,
C/EBPd, and GR, and plays a role similar to KLF9 in adipocyte
differentiation but exerts much stronger effects (Mori et al.,
2005). KLF15 also modulates adipogenic speciﬁc genes such as
GLUT4 and AceCS2, which are involved in energy metabolism in
mature adipocytes. KLF9 and KLF15 are likely to sustain PPARg
level in adipogenesis, although C/EBPb and C/EBPd decrease on
day 4. In addition, KLF15 and KLF9 act synergistically with C/EBPa
to activate PPARg promoters and maintain the expression of
PPARg in the differentiated state of 3T3-L1 cells.
Collectively, there are four members in KLF family involved in
adipocyte differentiation by regulating PPARg2 transcription.
KLF2 is expressed in 3T3-L1 preadipocytes, and its expression is
shut down upon differentiation. KLF5 is induced 4hrs afterFig. 1. Role of Kruppel-like factors in adipogenesis. Upon hormone cocktail (Dex,
differentiation, followed by a late stage of terminal differentiation into mature adipocy
adipocyte differentiation.stimulation, and its expression peak occurs at the early stage of
adipogenesis. KLF9 appears at the middle phase of differentiation
and gradually increases throughout the middle and late stages.
The expression pattern of KLF15 is similar to that of KLF9 and
reaches its highest level in mature adipocytes. Although the time
frame for each KLF binding to PPARg is different, they bind to the
same DNA elements, within the 0.6-kb PPARg2 upstream promo-
ter region, except for KLF15, whose binding target on the PPARg2
promoter has not been identiﬁed.
Five KLFs members have been identiﬁed to date to interact
with C/EBPs. KLF3 associates with C/EBPa promoter directly by
recruiting its corepressor protein CtBP in 3T3-L1 preadipocyte.
KLF4 induces C/EBPb and C/EBPd with Krox20 to promote adipo-
genesis at the early stage. KLF5, in concert with C/EBPb and
C/EBPd, transactivates the expression of PPARg and C/EBPa. And
ﬁnally, KLF9 and KLF15 appear at the middle stage of differentia-
tion lasting throughout the late stage of adipogenesis, acting
together with C/EBPa via directly binding to its promoter to
activate PPARg activity. These KLFs are expressed sequentially
during adipogenesis and, importantly, at least one KLF member’s
expression corresponds to C/EBPs at each stage in adipocyte
differentiation.Future directions
The KLFs emerging during adipocyte differentiation show an
important role in regulating this process. Due to similarity in their
recognition sequences (including GC- and CACCC-boxes of DNA)
and their similar expression patterns in adipogenesis, further
investigation is needed to explore the interaction between differ-
ent KLFs as a network. Is it possible that KLF6 could abrogate the
activation effect of KLF2 on DLK1? Do KLFs in regulating PPARg or
C/EBPa promoter activity in adipogenesis have spatiotemporal
expression or inner interaction? Moreover, the precise mechan-
ism of expression of KLFs regulating adipocyte differentiation is
still elusive.
KLFs play an essential role in adipogenesis. Understanding the
upstream factors that modulate KLFs expression will become
necessary in fat biology, which will provide new insights for use
against the growing prevalence of obesity in the modern world.
Cofactors are usually required for transcription factor regulation.
However, only a few interacting with KLFs have been reported,
making it an important focus in future KLFs research.
Finally, the roles of KLFs in adipogenesis discussed above are
mainly based on animal and cell culture studies. Data from
human adipose tissue or from population-based epidemiology
studies will better address the roles of KLFs in developing obesity.IBMX, Insulin) stimulation, preadipocytes progress through an early stage of
tes. Various members of the KLF family contribute to transcriptional control of the
Z. Wu, S. Wang / Developmental Biology 373 (2013) 235–243 241In conclusion, this review revealed an essential role of KLFs in
the complex regulation of gene transcription during adipogenesis
and their relationships in this process, although new activities
await discovery. Strategies for development of targeted therapies
for obesity-related diseases will arise as we continue to expand
our understanding of the adipogenic functions of KLFs and their
contribution to obesity.Acknowledgement
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